BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32451945)

  • 1. Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy.
    McIntyre CA; Zambirinis CP; Pulvirenti A; Chou JF; Gonen M; Balachandran VP; Kingham TP; D'Angelica MI; Brennan MF; Drebin JA; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2021 Jan; 28(1):539-549. PubMed ID: 32451945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
    Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.
    Maksymov V; Hogan M; Khalifa MA
    HPB (Oxford); 2013 Mar; 15(3):218-23. PubMed ID: 23374362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
    Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
    Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
    Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
    Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Operative Frozen Section Histology of the Pancreatic Resection Margins and Clinical Outcome of Patients with Adenocarcinoma of the Head of the Pancreas Undergoing Pancreaticoduodenectomy.
    Dikmen K; Kerem M; Bostanci H; Sare M; Ekinci O
    Med Sci Monit; 2018 Jul; 24():4905-4913. PubMed ID: 30007990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma.
    López JC; Ielpo B; Iglesias M; Pinilla FB; Sánchez-Velázquez P
    Langenbecks Arch Surg; 2024 Apr; 409(1):122. PubMed ID: 38607450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.
    Gnerlich JL; Luka SR; Deshpande AD; Dubray BJ; Weir JS; Carpenter DH; Brunt EM; Strasberg SM; Hawkins WG; Linehan DC
    Arch Surg; 2012 Aug; 147(8):753-60. PubMed ID: 22911074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
    Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Zhang Y; Frampton AE; Cohen P; Kyriakides C; Bong JJ; Habib NA; Spalding DR; Ahmad R; Jiao LR
    J Gastrointest Surg; 2012 Oct; 16(10):1875-82. PubMed ID: 22878786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on the clinical therapeutic effects of arterial first approach pancreatoduodenectomy in the treatment of borderline resectable pancreatic adenocarcinoma].
    Jin G; Zheng KL; Guo SW; Shao Z; Liu C; Shi XH; Liu RD; Bai SJ; Jiang H; Bian Y; Hu XG
    Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):909-915. PubMed ID: 29224265
    [No Abstract]   [Full Text] [Related]  

  • 15. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
    Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
    Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma.
    Schneider C; Sodergren MH; Pencavel T; Soggiu F; Bhogal RH; Khan AZ
    Surg Oncol; 2020 Dec; 35():211-217. PubMed ID: 32911213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
    Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?
    Lad NL; Squires MH; Maithel SK; Fisher SB; Mehta VV; Cardona K; Russell MC; Staley CA; Adsay NV; Kooby DA
    Ann Surg Oncol; 2013 Oct; 20(11):3626-33. PubMed ID: 23838908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.